(The Center Square) – Two Republican U.S. senators and a national pro-life organization say they want the Trump administration to explain why the U.S. Food and Drug Administration approved a new generic version of the abortion pill mifepristone.
In September, the FDA notified Evita Solutions that its generic version of the drug was approved. The decision came despite earlier statements from the FDA…
